High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report

Andy Pan, Imran Khan, Marlene Mansour, Bernadett Kovacs, Caitlin Richler, Christine Landry, Kimberley Do, Sydney Morin, Deb Purkayastha, Melissa Varsava, Emma Baun, Pierre Thabet

Open source

DOI: 10.9734/ijmpcr/2025/v18i1408
Published: 2025-01-30
Container: International Journal of Medical and Pharmaceutical Case Reports
Publisher: Sciencedomain International
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.9734/ijmpcr/2025/v18i1408,
  title = {High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report},
  author = {Andy Pan and Imran Khan and Marlene Mansour and Bernadett Kovacs and Caitlin Richler and Christine Landry and Kimberley Do and Sydney Morin and Deb Purkayastha and Melissa Varsava and Emma Baun and Pierre Thabet},
  year = {2025},
  journal = {International Journal of Medical and Pharmaceutical Case Reports},
  doi = {10.9734/ijmpcr/2025/v18i1408},
  url = {https://doi.org/10.9734/ijmpcr/2025/v18i1408}
}

RIS

TY  - JOUR
TI  - High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report
AU  - Andy Pan
AU  - Imran Khan
AU  - Marlene Mansour
AU  - Bernadett Kovacs
AU  - Caitlin Richler
AU  - Christine Landry
AU  - Kimberley Do
AU  - Sydney Morin
AU  - Deb Purkayastha
AU  - Melissa Varsava
AU  - Emma Baun
AU  - Pierre Thabet
PY  - 2025
JO  - International Journal of Medical and Pharmaceutical Case Reports
DO  - 10.9734/ijmpcr/2025/v18i1408
UR  - https://doi.org/10.9734/ijmpcr/2025/v18i1408
ER  -

APA

Pan, A., Khan, I., Mansour, M., Kovacs, B., Richler, C., Landry, C., Do, K., Morin, S., Purkayastha, D., Varsava, M., Baun, E., & Thabet, P. (2025). High-Dose Intravenous Epoprostenol and Adjunct Therapies for Refractory Raynaud’s Phenomenon Associated with Anti-Jo-1 Antibodies: A Case Report. International Journal of Medical and Pharmaceutical Case Reports. https://doi.org/10.9734/ijmpcr/2025/v18i1408

Source records

crossref · retrieved 2026-11-08T01:26:42.375Z